Evidence map›Paper›PMID 26222747›Full record

ArticleSexually transmitted diseases2015

Hydrogen Peroxide-Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1β, Independent of Bacterial Vaginosis.

Caroline Mitchell, David Fredricks, Kathy Agnew, Jane Hitti

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Sexually transmitted diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05022212 (Phase 2 Placebo-controlled Randomized Trial of LACTIN-V), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05022212 phase2completednot on this mapstarted 2021, after this paper: background citation

Phase 2 Placebo-controlled Randomized Trial of LACTIN-V (Lactobacillus Crispatus CTV-05) Among Women at High Risk of HIV Acquisition in Durban, South Africa

TypeinterventionalSponsorUniversity of California, San FranciscoRan2021 to 2023Enrolled45ConditionsBacterial Vaginosis, HIV InfectionsArmsLACTIN-V, Placebo
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Vaginal microbiome and its implications in preterm birth.Obstetrics & gynecology science · 2025
    Review
  6. Review
  7. Review
  8. Review
  9. Engineered Tissue Models to Decode Host-Microbiota Interactions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. Influence of cervicovaginal microbiota onMicrobial cell (Graz, Austria) · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Under conditions closely mimicking vaginal fluid,Microbiology (Reading, England) · 2023
    Article
  17. Article
  18. The Role of Hydrogen-Peroxide (HAntioxidants (Basel, Switzerland) · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Caroline MitchellFrom the *Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA; †Department of Obstetrics & Gynecology, University of Washington, Boston, MA; and ‡Fred Hutchinson Cancer Research Center, Seattle, WA.
David Fredricks
Kathy Agnew
Jane Hitti
Fred Hutch Cancer Center · USReproductive Science Center · USUniversity of Washington · US

Funding

Mechanisms for Racial Disparity in Preterm BirthR01HD041682 · NICHD · UNIVERSITY OF WASHINGTON · PI HITTI, JANE E · 2001 to 2006
$1.4M
Female Genital Innate Immune Response to Vaginal MicrobiotaK08AI087969 · NIAID · UNIVERSITY OF WASHINGTON · PI MITCHELL, CAROLINE M · 2010 to 2014
$636k
NIAID NIH HHS 1K08AI087969NIAID NIH HHS K08 AI087969NICHD NIH HHS HD-41682NICHD NIH HHS R01 HD041682
6 · The paper itself

Abstract

backgroundThe presence of hydrogen peroxide (H2O2)-producing lactobacilli in the vagina is associated with decreased rates of preterm birth and HIV acquisition. We hypothesize that this is due to immunomodulatory effects of these species.

methodsConcentrations of interleukin (IL)-1β, IL-6, IL-8, secretory leukocyte protease inhibitor, and human β-defensin 2 were quantified from vaginal swabs from 4 groups of women: women with and without bacterial vaginosis (BV) by Nugent score, further stratified by detection of H2O2-producing lactobacilli by semiquantitative culture. Ten quantitative polymerase chain reaction assays characterized the presence and quantity of select Lactobacillus and BV-associated species in each group. Levels of immune markers and bacteria were compared between the 4 groups using analysis of variance, Kruskal-Wallis, Mann-Whitney U, or χ tests.

resultsSwabs from 110 women from 4 groups were included: 26 had a normal Nugent score (BV-), and no H2O2-producing lactobacilli detected (H2O2-); 47 were BV-, H2O2+; 27 BV+, H2O2-; and 10 BV+, H2O2+. The groups were similar in age, marital status, and reproductive history, but not ethnicity: the BV-, H2O2- group had more white participants (P = 0.02). In women with and without BV, IL-1β was lower in the H2O2+ groups. Human β-defensin 2 was lowest in BV+ H2O2- women and highest in BV-, H2O2-. Secretory leukocyte protease inhibitor was lower in women with BV and did not differ by the presence of H2O2-producing lactobacilli. In regression analysis, higher quantities of Lactobacillus crispatus were associated with lower quantities of IL-1β. Detection and quantity of BV-associated species by quantitative polymerase chain reaction was significantly different between women with and without BV, but not between women with and without H2O2-producing lactobacilli within those groups.

conclusionsThe presence of H2O2-producing lactobacilli is associated with lower levels of some vaginal proinflammatory cytokines, even in women with BV.

Indexed as

AdultCarrier StateFemaleHumansHydrogen PeroxideLactobacillusPregnancyPregnancy Complications, InfectiousProspective StudiesUnited StatesVaginaVaginal SmearsVaginosis, BacterialHydrogen Peroxide

Identifiers

PMID26222747
PMCPMC4520248
OpenAlexW2416897418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.